 | • レポートコード：D0GIR-00588 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、特効性注射剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。特効性注射剤の種類別市場規模（中小分子、大分子）、用途別市場規模（統合失調症、その他の精神障害）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Eli Lilly、Medincel、Johnson & Johnson、Pfizer、DURECT、GlaxoSmithKline、Zogenix、Lupin Limited ・地域別グローバル市場分析 2015年-2020年 ・特効性注射剤の北米市場（アメリカ、カナダ、メキシコ） ・特効性注射剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・特効性注射剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・特効性注射剤の南米市場（ブラジル、アルゼンチン） ・特効性注射剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：中小分子、大分子 ・用途別分析：統合失調症、その他の精神障害 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Long-Acting Injectables market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Long-Acting Injectables market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Long-Acting Injectables market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Long-Acting Injectables market has been segmented into:
Small and Middle Sized Molecule
Large Sized Molecule
By Application, Long-Acting Injectables has been segmented into:
Schizophrenia
Other Psychotic Disorders
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Long-Acting Injectables market presented in the report. This section sheds light on the sales growth of different regional and country-level Long-Acting Injectables markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Long-Acting Injectables market.
The report offers in-depth assessment of the growth and other aspects of the Long-Acting Injectables market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Long-Acting Injectables Market Share Analysis
Long-Acting Injectables competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Long-Acting Injectables sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Long-Acting Injectables sales, revenue and market share for each player covered in this report.
The major players covered in Long-Acting Injectables are:
Eli Lilly
Medincel
Johnson & Johnson
Pfizer
DURECT
GlaxoSmithKline
Zogenix
Lupin Limited
Table of Contents
1 Long-Acting Injectables Market Overview
1.1 Product Overview and Scope of Long-Acting Injectables
1.2 Classification of Long-Acting Injectables by Type
1.2.1 Global Long-Acting Injectables Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Long-Acting Injectables Revenue Market Share by Type in 2019
1.2.3 Small and Middle Sized Molecule
1.2.4 Large Sized Molecule
1.3 Global Long-Acting Injectables Market by Application
1.3.1 Overview: Global Long-Acting Injectables Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Schizophrenia
1.3.3 Other Psychotic Disorders
1.4 Global Long-Acting Injectables Market by Regions
1.4.1 Global Long-Acting Injectables Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Long-Acting Injectables (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Long-Acting Injectables Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Long-Acting Injectables Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Long-Acting Injectables Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Long-Acting Injectables Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Long-Acting Injectables Status and Prospect (2015-2025)
2 Company Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eli Lilly SWOT Analysis
2.1.4 Eli Lilly Product and Services
2.1.5 Eli Lilly Long-Acting Injectables Revenue, Gross Margin and Market Share (2018-2019)
2.2 Medincel
2.2.1 Medincel Details
2.2.2 Medincel Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Medincel SWOT Analysis
2.2.4 Medincel Product and Services
2.2.5 Medincel Long-Acting Injectables Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Long-Acting Injectables Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Long-Acting Injectables Revenue, Gross Margin and Market Share (2018-2019)
2.5 DURECT
2.5.1 DURECT Details
2.5.2 DURECT Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 DURECT SWOT Analysis
2.5.4 DURECT Product and Services
2.5.5 DURECT Long-Acting Injectables Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GlaxoSmithKline SWOT Analysis
2.6.4 GlaxoSmithKline Product and Services
2.6.5 GlaxoSmithKline Long-Acting Injectables Revenue, Gross Margin and Market Share (2018-2019)
2.7 Zogenix
2.7.1 Zogenix Details
2.7.2 Zogenix Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Zogenix SWOT Analysis
2.7.4 Zogenix Product and Services
2.7.5 Zogenix Long-Acting Injectables Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lupin Limited
2.8.1 Lupin Limited Details
2.8.2 Lupin Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lupin Limited SWOT Analysis
2.8.4 Lupin Limited Product and Services
2.8.5 Lupin Limited Long-Acting Injectables Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Long-Acting Injectables Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Long-Acting Injectables Players Market Share
3.2.2 Top 10 Long-Acting Injectables Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Long-Acting Injectables Revenue and Market Share by Regions
4.2 North America Long-Acting Injectables Revenue and Growth Rate (2015-2020)
4.3 Europe Long-Acting Injectables Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Long-Acting Injectables Revenue and Growth Rate (2015-2020)
4.5 South America Long-Acting Injectables Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Long-Acting Injectables Revenue and Growth Rate (2015-2020)
5 North America Long-Acting Injectables Revenue by Countries
5.1 North America Long-Acting Injectables Revenue by Countries (2015-2020)
5.2 USA Long-Acting Injectables Revenue and Growth Rate (2015-2020)
5.3 Canada Long-Acting Injectables Revenue and Growth Rate (2015-2020)
5.4 Mexico Long-Acting Injectables Revenue and Growth Rate (2015-2020)
6 Europe Long-Acting Injectables Revenue by Countries
6.1 Europe Long-Acting Injectables Revenue by Countries (2015-2020)
6.2 Germany Long-Acting Injectables Revenue and Growth Rate (2015-2020)
6.3 UK Long-Acting Injectables Revenue and Growth Rate (2015-2020)
6.4 France Long-Acting Injectables Revenue and Growth Rate (2015-2020)
6.5 Russia Long-Acting Injectables Revenue and Growth Rate (2015-2020)
6.6 Italy Long-Acting Injectables Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Long-Acting Injectables Revenue by Countries
7.1 Asia-Pacific Long-Acting Injectables Revenue by Countries (2015-2020)
7.2 China Long-Acting Injectables Revenue and Growth Rate (2015-2020)
7.3 Japan Long-Acting Injectables Revenue and Growth Rate (2015-2020)
7.4 Korea Long-Acting Injectables Revenue and Growth Rate (2015-2020)
7.5 India Long-Acting Injectables Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Long-Acting Injectables Revenue and Growth Rate (2015-2020)
8 South America Long-Acting Injectables Revenue by Countries
8.1 South America Long-Acting Injectables Revenue by Countries (2015-2020)
8.2 Brazil Long-Acting Injectables Revenue and Growth Rate (2015-2020)
8.3 Argentina Long-Acting Injectables Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Long-Acting Injectables by Countries
9.1 Middle East & Africa Long-Acting Injectables Revenue by Countries (2015-2020)
9.2 Saudi Arabia Long-Acting Injectables Revenue and Growth Rate (2015-2020)
9.3 UAE Long-Acting Injectables Revenue and Growth Rate (2015-2020)
9.4 Egypt Long-Acting Injectables Revenue and Growth Rate (2015-2020)
9.5 South Africa Long-Acting Injectables Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Long-Acting Injectables Revenue and Market Share by Type (2015-2020)
10.2 Global Long-Acting Injectables Market Forecast by Type (2019-2024)
10.3 Small and Middle Sized Molecule Revenue Growth Rate (2015-2025)
10.4 Large Sized Molecule Revenue Growth Rate (2015-2025)
11 Global Long-Acting Injectables Market Segment by Application
11.1 Global Long-Acting Injectables Revenue Market Share by Application (2015-2020)
11.2 Long-Acting Injectables Market Forecast by Application (2019-2024)
11.3 Schizophrenia Revenue Growth (2015-2020)
11.4 Other Psychotic Disorders Revenue Growth (2015-2020)
12 Global Long-Acting Injectables Market Size Forecast (2021-2025)
12.1 Global Long-Acting Injectables Market Size Forecast (2021-2025)
12.2 Global Long-Acting Injectables Market Forecast by Regions (2021-2025)
12.3 North America Long-Acting Injectables Revenue Market Forecast (2021-2025)
12.4 Europe Long-Acting Injectables Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Long-Acting Injectables Revenue Market Forecast (2021-2025)
12.6 South America Long-Acting Injectables Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Long-Acting Injectables Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Long-Acting Injectables Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Long-Acting Injectables by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Long-Acting Injectables Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Long-Acting Injectables Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Eli Lilly Corporate Information, Location and Competitors
Table 6. Eli Lilly Long-Acting Injectables Major Business
Table 7. Eli Lilly Long-Acting Injectables Total Revenue (USD Million) (2017-2018)
Table 8. Eli Lilly SWOT Analysis
Table 9. Eli Lilly Long-Acting Injectables Product and Solutions
Table 10. Eli Lilly Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Medincel Corporate Information, Location and Competitors
Table 12. Medincel Long-Acting Injectables Major Business
Table 13. Medincel Long-Acting Injectables Total Revenue (USD Million) (2018-2019)
Table 14. Medincel SWOT Analysis
Table 15. Medincel Long-Acting Injectables Product and Solutions
Table 16. Medincel Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Johnson & Johnson Corporate Information, Location and Competitors
Table 18. Johnson & Johnson Long-Acting Injectables Major Business
Table 19. Johnson & Johnson Long-Acting Injectables Total Revenue (USD Million) (2017-2018)
Table 20. Johnson & Johnson SWOT Analysis
Table 21. Johnson & Johnson Long-Acting Injectables Product and Solutions
Table 22. Johnson & Johnson Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Pfizer Corporate Information, Location and Competitors
Table 24. Pfizer Long-Acting Injectables Major Business
Table 25. Pfizer Long-Acting Injectables Total Revenue (USD Million) (2017-2018)
Table 26. Pfizer SWOT Analysis
Table 27. Pfizer Long-Acting Injectables Product and Solutions
Table 28. Pfizer Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. DURECT Corporate Information, Location and Competitors
Table 30. DURECT Long-Acting Injectables Major Business
Table 31. DURECT Long-Acting Injectables Total Revenue (USD Million) (2017-2018)
Table 32. DURECT SWOT Analysis
Table 33. DURECT Long-Acting Injectables Product and Solutions
Table 34. DURECT Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. GlaxoSmithKline Corporate Information, Location and Competitors
Table 36. GlaxoSmithKline Long-Acting Injectables Major Business
Table 37. GlaxoSmithKline Long-Acting Injectables Total Revenue (USD Million) (2017-2018)
Table 38. GlaxoSmithKline SWOT Analysis
Table 39. GlaxoSmithKline Long-Acting Injectables Product and Solutions
Table 40. GlaxoSmithKline Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Zogenix Corporate Information, Location and Competitors
Table 42. Zogenix Long-Acting Injectables Major Business
Table 43. Zogenix Long-Acting Injectables Total Revenue (USD Million) (2017-2018)
Table 44. Zogenix SWOT Analysis
Table 45. Zogenix Long-Acting Injectables Product and Solutions
Table 46. Zogenix Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Lupin Limited Corporate Information, Location and Competitors
Table 48. Lupin Limited Long-Acting Injectables Major Business
Table 49. Lupin Limited Long-Acting Injectables Total Revenue (USD Million) (2017-2018)
Table 50. Lupin Limited SWOT Analysis
Table 51. Lupin Limited Long-Acting Injectables Product and Solutions
Table 52. Lupin Limited Long-Acting Injectables Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Long-Acting Injectables Revenue (Million USD) by Players (2015-2020)
Table 54. Global Long-Acting Injectables Revenue Share by Players (2015-2020)
Table 55. Global Long-Acting Injectables Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Long-Acting Injectables Revenue Market Share by Regions (2015-2020)
Table 57. North America Long-Acting Injectables Revenue by Countries (2015-2020)
Table 58. North America Long-Acting Injectables Revenue Market Share by Countries (2015-2020)
Table 59. Europe Long-Acting Injectables Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Long-Acting Injectables Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Long-Acting Injectables Revenue by Countries (2015-2020)
Table 62. South America Long-Acting Injectables Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Long-Acting Injectables Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Long-Acting Injectables Revenue Market Share by Countries (2015-2020)
Table 65. Global Long-Acting Injectables Revenue (Million USD) by Type (2015-2020)
Table 66. Global Long-Acting Injectables Revenue Share by Type (2015-2020)
Table 67. Global Long-Acting Injectables Revenue Forecast by Type (2021-2025)
Table 68. Global Long-Acting Injectables Revenue by Application (2015-2020)
Table 69. Global Long-Acting Injectables Revenue Share by Application (2015-2020)
Table 70. Global Long-Acting Injectables Revenue Forecast by Application (2021-2025)
Table 71. Global Long-Acting Injectables Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Long-Acting Injectables Picture
Figure 2. Global Long-Acting Injectables Revenue Market Share by Type in 2019
Figure 3. Small and Middle Sized Molecule Picture
Figure 4. Large Sized Molecule Picture
Figure 5. Long-Acting Injectables Revenue Market Share by Application in 2019
Figure 6. Schizophrenia Picture
Figure 7. Other Psychotic Disorders Picture
Figure 8. Global Long-Acting Injectables Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Long-Acting Injectables Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Long-Acting Injectables Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Long-Acting Injectables Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Long-Acting Injectables Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Long-Acting Injectables Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Long-Acting Injectables Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Long-Acting Injectables Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Long-Acting Injectables Revenue Market Share in 2019
Figure 17. Global Top 10 Players Long-Acting Injectables Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Long-Acting Injectables Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Long-Acting Injectables Revenue Market Share by Regions (2015-2020)
Figure 21. Global Long-Acting Injectables Revenue Market Share by Regions in 2018
Figure 22. North America Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 23. Europe Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 25. South America Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 27. North America Long-Acting Injectables Revenue Market Share by Countries (2015-2020)
Figure 28. North America Long-Acting Injectables Revenue Market Share by Countries in 2019
Figure 29. USA Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 30. Canada Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 32. Europe Long-Acting Injectables Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Long-Acting Injectables Revenue Market Share by Countries in 2019
Figure 34. Germany Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 35. UK Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 36. France Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 37. Russia Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 38. Italy Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Long-Acting Injectables Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Long-Acting Injectables Revenue Market Share by Countries in 2019
Figure 41. China Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 42. Japan Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 43. Korea Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 44. India Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 46. South America Long-Acting Injectables Revenue Market Share by Countries (2015-2020)
Figure 47. South America Long-Acting Injectables Revenue Market Share by Countries in 2019
Figure 48. Brazil Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Long-Acting Injectables Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Long-Acting Injectables Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 53. UAE Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Long-Acting Injectables Revenue and Growth Rate (2015-2020)
Figure 56. Global Long-Acting Injectables Revenue Share by Type (2015-2020)
Figure 57. Global Long-Acting Injectables Revenue Share by Type in 2019
Figure 58. Global Long-Acting Injectables Market Share Forecast by Type (2021-2025)
Figure 59. Global Small and Middle Sized Molecule Revenue Growth Rate (2015-2020)
Figure 60. Global Large Sized Molecule Revenue Growth Rate (2015-2020)
Figure 61. Global Long-Acting Injectables Revenue Share by Application (2015-2020)
Figure 62. Global Long-Acting Injectables Revenue Share by Application in 2019
Figure 63. Global Long-Acting Injectables Market Share Forecast by Application (2021-2025)
Figure 64. Global Schizophrenia Revenue Growth Rate (2015-2020)
Figure 65. Global Other Psychotic Disorders Revenue Growth Rate (2015-2020)
Figure 66. Global Long-Acting Injectables Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Long-Acting Injectables Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Long-Acting Injectables Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Long-Acting Injectables Revenue Market Forecast (2021-2025)
Figure 70. Europe Long-Acting Injectables Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Long-Acting Injectables Revenue Market Forecast (2021-2025)
Figure 72. South America Long-Acting Injectables Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Long-Acting Injectables Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
基礎インスリン（長時間作用型インスリン）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Basal Insulin (Long-Acting Insulin) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…- 複動シリンダーの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Double-acting Cylinders market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Double-acting Cylinde…
- 直動式高速サーボバルブ（DASV）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Direct Acting High Speed Servo Valve (DASV) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…
- CISインスリンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global CIS Insulin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The CIS Insulin market report provide…
- ロングレーダーシステムの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Long Radar System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Long Radar System market re…